Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial

By Balen Adam   Platteau Peter   Andersen Anders Nyboe   Devroey Paul   Helmgaard Lisbeth   Arce Joan-Carles  

Human Reproduction, Vol. 22, Iss. 7, 2007-07 ,pp. : 1816-1823

Oxford University Press

Access to resources Recommend Favorite

Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study

By Hugues J.N.  

Human Reproduction, Vol. 20, Iss. 3, 2005-03 ,pp. : 629-635

Oxford University Press

Access to resources Recommend Favorite

Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study

By Platteau Peter   Andersen Anders Nyboe   Balen Adam   Devroey Paul   Sørensen Per   Helmgaard Lisbeth   for the Menopur Ovulation Induction (MOI) Study Group  

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1798-1804

Oxford University Press

Access to resources Recommend Favorite

Management of anovulatory infertility associated with polycystic ovary syndrome: tamoxifen citrate an effective alternative compound to clomiphene citrate

By Nardo LG  

Gynecological Endocrinology, Vol. 19, Iss. 5, 2004-11 ,pp. : 235-238

Informa Healthcare

Access to resources Recommend Favorite

Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment.

By Roozenburg B J   van Dessel H J   Evers J L   Bots R S  

Human Reproduction, Vol. 12, Iss. 8, 1997-08 ,pp. : 1720-1722

Oxford University Press

Access to resources Recommend Favorite